Insider Trends: Insider Disposition Eases Back 90-Day Buy Trend at Adicet Bio
04:06 PM EDT, 05/07/2021 (MT Newswires) -- Chen Schor, Director and President & CEO, on May 05, 2021, sold 16,466 shares in Adicet Bio (ACET) for $234,222. Subsequent to the Form 4 filing with the SEC, Schor indirectly controls 116,782 shares of the company, which has a market value of $1.66 million as of the prior-day closing price.
Over the last 90 days, previous to the date of this filing, there have been 7 insider transactions reported to the SEC for Adicet Bio. These transactions came from the activities of 4 separate insiders that resulted in a net acquisition of 1,507,183 company shares. This compares with the preceding 90-day window of time where there were 2 transactions from 1 insider that resulted in the disposition of 4,957 shares.
This is below the average for insider transactions in the 150-company Pharmaceuticals peer group over the last 90-day period. Activity in the peer group averaged 64.2 transactions per company, and disposition of 7,243 shares on average.
SEC Story Link http://www.sec.gov/Archives/edgar/data/1720580/000120919121030874/xslF345X03/doc4.xml
This report does not constitute a recommendation to purchase or sell any security and the analysts are not registered investment advisors. Further analysis is recommended before undertaking any position in any security. Any risks are solely the responsibility of the buyer/seller. The authors, publishers and distributors of the MT Newswires Live Briefs service and any associates thereof accept no liability for the content or actions taken by anyone or institution utilizing this report.